↓ Skip to main content

Vedolizumab in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Safety, Efficacy, and Place of Therapy

Overview of attention for article published in Core Evidence, April 2020
Altmetric Badge

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Vedolizumab in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Safety, Efficacy, and Place of Therapy
Published in
Core Evidence, April 2020
DOI 10.2147/ce.s179053
Pubmed ID
Authors

Noritaka Takatsu, Takashi Hisabe, Daijiro Higashi, Toshiharu Ueki, Toshiyuki Matsui

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 14%
Student > Postgraduate 5 10%
Student > Master 4 8%
Student > Ph. D. Student 4 8%
Researcher 3 6%
Other 8 16%
Unknown 20 39%
Readers by discipline Count As %
Medicine and Dentistry 15 29%
Pharmacology, Toxicology and Pharmaceutical Science 5 10%
Chemistry 2 4%
Business, Management and Accounting 1 2%
Immunology and Microbiology 1 2%
Other 7 14%
Unknown 20 39%